Non-drug therapy for controlling cough in patients with lung disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates a non-pharmacological cough control therapy aimed at treating chronic cough in patients with interstitial lung disease (ILD). It seeks to determine the feasibility and effectiveness of this therapy when used alongside pulmonary rehabilitation. The research will involve adults with ILD and chronic cough lasting more than eight weeks, who will be recruited from outpatient programs and may participate through virtual interactions. The study will assess improvements in health-related quality of life and cough-related symptoms compared to pulmonary rehabilitation alone.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Individuals will be included if having confirmed diagnosis of any ILD by a physician (as per Canadian Thoracic Society's guideline for evaluating patients with fibrotic interstitial lung disease) and a chronic cough lasting more than 8 weeks in duration

Exclusion Criteria:

* self-reports of moderate or large sputum production
* effective or suspected exacerbation of the respiratory condition in the past month
* upper respiratory tract infection in the past month
* use of angiotensin-converting enzyme inhibitor medication
* changes in the prescribed medication in the previous month
* evidence of traction bronchiectasis in the HRCT
* evidence of other medical conditions that prevent performance of an exercise training program
* unable to read or speak in English / unable to provide informed consent.

Where it's running

• St. Joseph's Healthcare Hamilton
  Hamilton, Ontario, Canada Recruiting
• West Park Healthcare Centre
  Toronto, Ontario, Canada Recruiting

Study contacts

• Study coordinator: Ana Oliveira, PhD
• Email: ana.oliveira@westpark.org
• Phone: 6477651525

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Remifentanil With or Without Lidocaine for Extubation After Thyroid Surgery

  This study tests whether adding intravenous lidocaine to remifentanil during awakening reduces coughing after thyroidectomy extubation in adults.

  Recruiting Phase 4 Pamukkale University · Denizli · NCT07857356

• Photon-counting CT vs standard HRCT to help diagnose IPF and other ILDs

  This study tests whether photon-counting CT can improve identifying IPF and other ILDs compared with standard HRCT for patients discussed in multidisciplinary teams.

  Recruiting Istituto Clinico Humanitas · Rozzano, Italy · NCT07790614

• AccuPulmo CT Portal for Detecting Pulmonary Fibrosis on Chest CT

  This study tests how well the AccuPulmo CT Portal can identify pulmonary fibrosis on existing chest CT scans from adults at Taichung Veterans General Hospital.

  Recruiting Taichung Veterans General Hospital · Taichung · NCT07761377

• Oliceridine vs Sufentanil for cough during anesthesia induction

  This trial tests whether oliceridine is better than sufentanil at reducing cough during anesthesia induction in adults undergoing elective surgery.

  Recruiting Phase 4 Shanghai Pulmonary Hospital, Shanghai, China · Tianmen, Hubei · NCT07660380

• Advanced imaging to see how immunosuppression affects lung fibrosis activity

  This trial will test whether immunosuppression changes PET and MRI measurements of active collagen deposition and tissue injury in people with non‑IPF interstitial lung disease who are starting treatment.

  Recruiting Phase 2 Massachusetts General Hospital · Boston, Massachusetts · NCT07572383

• 68Ga-NI-FAPI-04 PET/CT imaging to detect fibroblast activation in cancer, fibrotic, and heart diseases

  This test will see if an injected PET tracer called 68Ga-NI-FAPI-04 can better show fibroblast activation in people with tumors, pulmonary fibrosis, certain autoimmune vascular diseases, hypertrophic cardiomyopathy, or other cardiovascular conditions.

  Recruiting Phase 1/2 Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07464132

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.